SCHEMBL7465138

SCHEMBL7465138

CC(=O)c1cccc(Nc2nccc(-c3cccnc3)n2)c1

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 19/20 0.80
BCR P11274 16/20 0.80
PRKCA P17252 8/20 0.80
SRC P12931 9/20 0.79
PRKCD Q05655 6/20 0.76
PDGFRB P09619 6/20 0.76
PDGFRA P16234 6/20 0.76
PRKD3 O94806 1/20 0.74
PRKCG P05129 1/20 0.74
PRKCB P05771 1/20 0.74
PRKCH P24723 1/20 0.74
PRKCI P41743 1/20 0.74
PRKCE Q02156 1/20 0.74
PRKCQ Q04759 1/20 0.74
PRKCZ Q05513 1/20 0.74
PRKD1 Q15139 1/20 0.74
EGFR P00533 3/20 0.67
PRKACA P17612 1/20 0.67
PRKACG P22612 1/20 0.67
PRKACB P22694 1/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1655099 0.89 ABL1 (1.00) ABL1BCRPRKCASRCPRKCD
SCHEMBL1927119 0.88 ABL1 (1.00) ABL1BCRPRKCASRCPRKCD
SCHEMBL4895454 0.88 ABL1 (0.80) ABL1BCRPRKCASRCPRKCD
SCHEMBL14088818 0.88 ABL1 (0.80) ABL1BCRPRKCASRCPRKCD
SCHEMBL7468958 0.88 ABL1 (0.76) ABL1BCRPRKCASRCPRKCD
Hydrochloric Acid SCHEMBL27711429 0.87 ABL1 (0.79) ABL1BCRPRKCASRCPRKCD
SCHEMBL11924749 0.87 ABL1 (0.62) ABL1BCRPRKCASRCPRKCD
SCHEMBL7467179 0.86 ABL1 (0.69) ABL1BCRPRKCASRCPRKCD
SCHEMBL1522 0.86 ABL1 (1.00) ABL1BCRPRKCASRCPRKCD
Hydrochloric Acid SCHEMBL27708725 0.86 ABL1 (0.77) ABL1BCRPRKCASRCPRKCD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080187575-A1 Pyrimidine Derivatives VICHEM CHEMIE KFT (HU) 2008-08-07 US disclosed
EP-0233461-B2 4,5,6-Substituted-2-pyrimidinamines AMERICAN CYANAMID CO (US) 2002-05-29 EP disclosed
EP-0233461-B1 4,5,6-Substituted-2-pyrimidinamines AMERICAN CYANAMID CO (US) 1996-03-20 EP disclosed
US-4876252-A ADMINISTERING ANTIASTHMATIC OR ANTIALLERGEN AMERICAN CYANAMID COMPANY (US) 1989-10-24 US disclosed
US-4788195-A TREATING ASTHMA, ALLERGIC DISEASES, INFLAMMATION AND DIABETES IN MAMMALS AMERICAN CYANAMID COMPANY (US) 1988-11-29 US disclosed
EP-0233461-A2 4,5,6-Substituted-2-pyrimidinamines AMERICAN CYANAMID COMPANY (US) 1987-08-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080187575-A1 Pyrimidine Derivatives TYMP, TDP1, PNP ABL1 2843/4885BCR 2315/4885PRKCA 2607/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.